This is an aggregated industry headline. Read the full story at Pharmaceutical Technology →
MSD wins FDA approval for cholesterol pill to help plug Keytruda void
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
By Pharmaceutical Technology
· Jul 17, 2026
· via Pharmaceutical Technology
Image: Pharmaceutical Technology
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlinePharmaceutical Technology
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Foundation Medicine has started the "Quality First" initiative to create awareness of how "not all cancer biom…
The WeekFierceBiotech ↗
GSK has ended development of camlipixant in chronic cough after delivering mixed phase 3 data, dealing a major…
The WeekSTAT News ↗
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 98…